CIK 0000728387 · Non-accelerated filer<br>Smaller reporting company
Perspective Therapeutics, Inc.
Sign in to watch- Ticker
- CATX
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 411458152
- Phone
- 206-676-0900
- Business address
- 2401 ELLIOTT AVENUE, SUITE 320, SEATTLE, WA, 98121
- Former names
- IsoRay, Inc., Isoray, Inc., CENTURY PARK PICTURES CORP
- SC 13G Stake Amended Statement of Ownership
- 8-K/A Event Exhibits
- 424B5 Offering Prospectus
- 4 Open-market sale Controller sold 11,334 shares at an average $0.99 ($11,221)
- 8-K Event Material agreement · Other events
- S-3MEF Other S-3MEF
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4/A Open-market buy CEO bought 10,000 shares at an average $0.52 ($5,155)
- 4/A Open-market buy CEO bought 10,500 shares at an average $0.54 ($5,655)
- 4/A Open-market buy CEO bought 20,000 shares at $0.68 ($13,600)
- 4/A Open-market buy CEO bought 4,500 shares at an average $0.80 ($3,611)
- 4 Open-market buy CEO bought 10,000 shares at an average $0.52 ($5,155)
- 4 Open-market buy CEO bought 10,500 shares at an average $0.54 ($5,655)
- 4 Open-market buy CEO bought 20,000 shares at $0.68 ($13,600)
- 4 Open-market buy CEO bought 4,600 shares at an average $0.80 ($3,696)
- 4 Open-market buy CEO bought 10,000 shares at an average $0.52 ($5,155)
Page 39 of 58 · 1,148 filings